Pharma COVID Roundup: News from Pfizer, Merck & Co., and Sanofi
By

By
The latest from pharma companies on potential COVID-19 treatments with news from Pfizer, Merck & Co., Sanofi, AstraZeneca, Theravance and Inovio. News from Pfizer, Merck & Co., Sanofi, and AstraZeneca…

Takeda, ProThera Biologics Form Licensing Pact for Plasma-Derived Therapies
By

By
Takeda and ProThera Biologics, a Providence, Rhode Island-based development company, have entered into a global licensing agreement to develop a plasma-derived inter-alpha inhibitor proteins (IAIP) therapy for the treatment of…

Pharma COVID-19 Relief Roundup: News from Teva, Bayer, and Merck & Co.
By

By
The latest contributions from Teva, Bayer, and Merck & Co., in funding and donations supporting relief efforts against COVID-19. Teva Donates Potential COVID-19 Drugs Hydroxychloroquine and AzithromycinTeva Pharmaceutical Industries has outlined…

Gilead, oNKo-innate Form Pact for Cancer Immunotherapies
By

By
Gilead Sciences, its subsidiary, Kite, and oNKo-innate, a Melbourne, Australia-based discovery-stage company for immuno-oncology drug development, have entered into a three-year cancer immunotherapy research collaboration to support discovery and development…

US Gov’t Grants $483 M to Moderna for mRNA COVID Vaccine Candidate
By

By
Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has announced an agreement for a commitment of up to $483 million from the Biomedical Advanced Research and Development Authority (BARDA) within…

Pharma COVID Roundup: News from Novartis, Pfizer, and AstraZeneca
By

By
The latest from pharma companies on potential COVID-19 treatments with news from Novartis, Pfizer, AstraZeneca, Biogen, Bayer, Alexion, Fujifilm, and Celltrion. News from Novartis, Pfizer, AstraZeneca, Biogen and Bayer Novartis…

Pharma Companies Advance Potential COVID-19 Treatments
By

By
The latest from pharma companies on potential COVID-19 treatments with news from Lilly, Sanofi, GSK, AstraZeneca, CSL Behring, and Bausch Health. Lilly, US Gov’t Partner To Study Potential COVID-19 TherapyEli…

Pharma Companies Step Up Relief Efforts Against COVID-19
By

By
The latest contributions from J&J, Gilead, BMS, Merck & Co, Bayer, Novo Nordisk, Lilly, and Daiichi Sankyo in funding and donations supporting relief efforts against COVID-19. J&J Commits $50 M…

Alnylam, Blackstone Sign $2-Bn Financing Pact for RNAi Therapies
By

By
Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA interference (RNAi) therapeutics, and Blackstone Life Sciences, a private investment firm, have formed a collaboration under which Blackstone will provide up to $2…

Pharma COVID Roundup: News from Novartis, Amgen, Pfizer, and GSK
By

By
The latest from pharma companies on developments of potential COVID-19 treatments with news from Novartis, Amgen, Pfizer, GSK, CSL, Takeda, Biotest, Inovio Pharmaceuticals, and Hope Biosciences. In this roundup: Novartis…